Pill with rp
Searched over 200M research papers
Summary
6 papers analyzed
These studies suggest that various pills and treatments, including a robotic pill for drug delivery, exposure and ritual prevention for OCD, contraceptive rings and pills for bleeding patterns, Ruyi Zhenbao Pill for osteoarthritis, and reminder packaging for antihypertensive therapy, are effective in their respective applications, with varying degrees of success and improvements in symptoms, adherence, and quality of life.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Robotic Pill (RP) for Oral Delivery of Biotherapeutics
Introduction to Robotic Pill (RP) Technology
Biotherapeutics, while highly effective, often suffer from poor patient compliance due to the pain and inconvenience associated with chronic injections. The development of an orally ingestible robotic pill (RP) aims to address these challenges by providing a pain-free, reliable method for delivering biotherapeutic drugs directly into the small intestine.
Mechanism and Performance of the Robotic Pill
The RP is designed to protect the biotherapeutic drug payload from degradation in the gastrointestinal (GI) tract and to auto-inject it into the wall of the small intestine. This is achieved through the inflation of a balloon within the RP, which then deflates immediately after drug delivery. The intestines are insensate to sharp stimuli, making this method pain-free.
Clinical Studies on Safety and Efficacy
Two clinical studies have demonstrated the safety, tolerability, and performance of the RP in healthy humans. In the first study, three versions of the RP, differing only in balloon diameter, were tested. The RP successfully delivered a biotherapeutic (octreotide) in varying proportions of subjects, with a mean bioavailability of 65% based on successful drug deliveries in groups A and B. The reliability of drug delivery ranged from 25% to 80%, with success rates directly related to balloon size.
In a separate study, the deployment of the RP was found to be unaffected by fed or fasting conditions, suggesting that the RP can be taken with or without food. These promising results indicate that biotherapeutics currently administered parenterally could be safely and reliably delivered via this versatile, orally ingestible drug delivery platform.
Conclusion
The development of the robotic pill (RP) represents a significant advancement in the oral delivery of biotherapeutics. By providing a safe, pain-free, and reliable method for drug delivery, the RP has the potential to improve patient compliance and overall disease management. The clinical studies underscore the RP's efficacy and versatility, paving the way for its potential use in delivering a wide range of biotherapeutic drugs.
Sources and full results
Most relevant research papers on this topic
